CIVI BIOPHARMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Jun 2020)
What this means for you
This application is over — abandoned 22 Jun 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87801002
- Mark type
- Stylized text
- Filed
- 16 Feb 2018
- Published for opposition
- 25 Sept 2018
- Abandoned
- 22 Jun 2020
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; research and development in the field of cardiology
Owner
- CiVi Biopharma, Inc., Bryn Mawr, PA, US
- CiVi Biopharma, Inc., Bryn Mawr, PA, US
Prosecution history
- 22 Jun 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Jun 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2020 — CORRECTED NOA E-MAILED
- 02 Mar 2020 — DIVISIONAL PROCESSING COMPLETE
- 29 Jan 2020 — DIVISIONAL REQUEST RECEIVED
- 02 Mar 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Jan 2020 — TEAS REQUEST TO DIVIDE RECEIVED
- 22 Nov 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2019 — SOU EXTENSION 2 GRANTED
- 20 Nov 2019 — SOU EXTENSION 2 FILED
- 20 Nov 2019 — SOU TEAS EXTENSION RECEIVED
- 21 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 May 2019 — SOU EXTENSION 1 GRANTED
- 17 May 2019 — SOU EXTENSION 1 FILED
- 17 May 2019 — SOU TEAS EXTENSION RECEIVED